Trial Profile
A Randomized, Double-blind, Vehicle- and Placebo-Controlled, Multicenter Trial in Patients With Mild to Moderate Distal Subungual Toenail Onychomycosis to Investigate the Efficacy, Tolerability, and Safety of Twice Daily Application of TDT 067 for 48 Weeks
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 23 May 2014
Price :
$35
*
At a glance
- Drugs Terbinafine (Primary)
- Indications Onychomycosis
- Focus Registrational; Therapeutic Use
- Sponsors Celtic Pharma
- 23 May 2014 New trial record